Medicine and Dentistry
Vocal Folds
100%
Recurrent Laryngeal Nerve
78%
Paralysis
65%
Wart Virus
47%
Head and Neck Cancer
43%
Reinnervation
43%
Disease
41%
Head and Neck Squamous Cell Carcinoma
40%
Malignant Neoplasm
40%
Radiation Therapy
39%
Neoplasm
38%
Neck
33%
Recurrent Laryngeal Nerve Injury
33%
Injury
30%
Oropharynx Squamous Cell Carcinoma
29%
Larynx
28%
Overall Survival
27%
Hazard Ratio
27%
Free Tissue Graft
26%
Oropharynx Carcinoma
25%
Surgery
24%
Nerve Regeneration
23%
Spasmodic dysphonia
22%
Medicine
21%
Induction Chemotherapy
20%
Surgeon
20%
Nerve Transection
20%
Paclitaxel
19%
Squamous Cell Carcinoma
19%
Laryngoplasty
18%
Innervation
17%
Cisplatin
17%
Vincristine
16%
Axon
16%
Quality of Life
16%
Donor Site
16%
Clinical Trial
15%
Fibula
14%
Hypoglossal Nerve
14%
Health Care
14%
Lymph Node
14%
Surgical Technique
14%
Action Potential
13%
Disease Specific Survival
13%
Disease Free Survival
13%
Oral Cavity
13%
Phonation
12%
Laryngeal Nerve
12%
Recurrent Disease
12%
Electromyography
12%
Keyphrases
Recurrent Laryngeal Nerve
79%
Practical Guide
62%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
52%
Head-and-neck Cancer
48%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
48%
Adductor
44%
Unilateral Vocal Fold Paralysis
42%
High-risk Human Papillomavirus (HR-HPV)
42%
Confidence Interval
42%
Canine
38%
Reinnervation
36%
Recurrent Laryngeal Nerve Injury
35%
Locally Advanced
33%
Laryngeal Reinnervation
30%
Head-and-neck
29%
Overall Survival
29%
Posterior Cricoarytenoid muscle
28%
Induction Chemotherapy
26%
Radiation Therapy
26%
Vocal Fold
25%
Cisplatin
24%
Primary Dystonia
24%
Adductor Spasmodic Dysphonia
24%
Hazard Ratio
21%
Nerve Transection
20%
Nab-paclitaxel
19%
Canine Model
19%
Upper Aerodigestive Tract Cancer
19%
Neoadjuvant
19%
Botulinum Toxin Injection
18%
Phase II Trial
18%
Flap
18%
Disease-specific Survival
18%
Radial Forearm Free Flap
17%
Multivariable
17%
Compound muscle Action Potential
17%
Nerve
17%
Tumor
16%
Disease-free Survival
16%
Surgeons
16%
Surveillance Strategy
15%
Zn Isotopes
15%
Cetuximab
15%
Functional Recovery
15%
Bilateral Vocal Fold Paralysis
15%
Laryngoscope
15%
V-RQOL
15%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
14%
Etiology
14%
Muscle Stem Cell (MuSC)
14%